<DOC>
	<DOCNO>NCT00653978</DOCNO>
	<brief_summary>The aim present study compare effect unilateral versus bilateral stenting patient malignant hilar obstruction .</brief_summary>
	<brief_title>Unilateral Versus Bilateral Stents Bismuth Type II III Malignant Hilar Strictures</brief_title>
	<detailed_description>Cholangiocarcinoma account 3 % gastrointestinal cancer second commonest primary liver cancer . However patient suitable surgical resection therefore endoscopic biliary drainage use palliative treatment modality malignant hilar stricture . However , whether one two stent benefit patient still define . Numerous retrospective case series reach different conclusion , till , one randomize trial compare effect unilateral versus bilateral stenting patient malignant hilar obstruction , nonetheless , nearly one third patient Bismuth Type I stricture , one stent enough drainage situation , therefore , best drainage strategy patient Bismuth Type II Bismuth Type III malignant hilar obstruction unknown . The aim present study compare effect unilateral versus bilateral stenting patient Bismuth Type II III malignant hilar obstruction .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<criteria>Consecutive untreated patient biliary obstruction ( Bismuth type II , III ) hilum due primary cholangiocarcinoma , gallbladder cancer , periportal lymph node metastasis . Diagnosis base US , CT , MRCP . Histologic cytologic confirmation malignancy establish percutaneous biopsy ( US CTguided ) endoscopic tissue sampling , endoscopic brushing . Or diagnosis base typical feature image expected clinical outcome followup . All patient consider unsuitable resection basis general medical condition and/or tumor extent . Full inform consent obtain . Refuse participate study . Refuse provide inform consent . Refuse place plastic stent . Physically unfit endoscopic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>ERCP</keyword>
	<keyword>cholangiocarcinoma</keyword>
	<keyword>hilar stricture</keyword>
</DOC>